Free Account Opening + AMC Free Demat
Loading...

Alkem Laboratories IPO vs Dr Lal PathLabs IPO

Comparision between Alkem Laboratories IPO and Dr Lal PathLabs IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Dr Lal PathLabs IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the Dr Lal PathLabs IPO is up to ₹638.00 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Dr Lal PathLabs IPO is ₹550.00 per share.

  Alkem Laboratories IPO Dr Lal PathLabs IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹540.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹550.00 per share
Issue Price (Final) ₹1,050.00 per share ₹550.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 20 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 1,28,53,442 shares 1,16,00,000 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹638.00 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while Dr Lal PathLabs IPO opens on Dec 08, 2015. The closing date of Alkem Laboratories IPO and Dr Lal PathLabs IPO is Dec 10, 2015, and Dec 10, 2015, respectively.

  Alkem Laboratories IPO Dr Lal PathLabs IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Dec 08, 2015
Issue Close Dec 10, 2015 Dec 10, 2015
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to Dr Lal PathLabs IPO P/E ratio of .

  Alkem Laboratories IPO Dr Lal PathLabs IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income6,401.175,438.974,238.613,199.03
Profit After Tax (PAT)879.69739.53488.75410.09
Promoter Shareholding (Pre-Issue) 70.87% 63.67%
Promoter Shareholding (Post-Issue) 66.23% 58.7%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 15.4%% 27.85%%

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in Dr Lal PathLabs IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 23,20,000 shares in Dr Lal PathLabs IPO.

  Alkem Laboratories IPO Dr Lal PathLabs IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 23,20,000 shares
NII 18,83,179 shares 17,40,000 shares
RII 43,94,086 shares 40,60,000 shares
Employee 2,98,913 shares
Others
Total 90,87,084 shares 81,20,000 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas Dr Lal PathLabs IPO subscribed 33.41x.

  Alkem Laboratories IPO Dr Lal PathLabs IPO
QIB (times) 57.19x 63.56x
NII (times) 129.96x 61.28x
Big NII (times)
Small NII (times)
RII (times) 3.17x 4.24x
Employee (times) 0.67x
Other (times)
Total (times) 44.29x 33.41x

Comments

Add a public comment...